Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO11632 | Fructus phyllanthi | NA | NA | NA | HerDing* | |||
NPO26650 | Terminalia chebula | Species | Combretaceae | Eukaryota | HerDing* | |||
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | HerDing* | |||
NPO3942 | Geranium pratense | Species | Geraniaceae | Eukaryota | HerDing* | |||
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | TM-MC* | |||
NPO22244 | Terminalia bellirica | Species | Combretaceae | Eukaryota | TM-MC* | |||
NPO26650 | Terminalia chebula | Species | Combretaceae | Eukaryota | TM-MC* | |||
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | TCMID* | |||
NPO11632 | Fructus phyllanthi | NA | NA | NA | TCMID* | |||
NPO26650 | Terminalia chebula | Species | Combretaceae | Eukaryota | TCMID* | |||
NPO3942 | Geranium pratense | Species | Geraniaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT44 | Individual Protein | Bifunctional protein glmU | Mycobacterium tuberculosis | IC50 | > | 9999000 | nM | PubChem BioAssay data set |
NPT45 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens | Potency | = | 891.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 112.2 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 707.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 398.1 | nM | PubChem BioAssay data set | |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 2.2 | nM | PubChem BioAssay data set |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 31.6 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT52 | Individual Protein | Pyruvate kinase isozymes M1/M2 | Homo sapiens | Potency | = | 112.2 | nM | PubChem BioAssay data set |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT60 | Individual Protein | Lysosomal alpha-glucosidase | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 3971.6 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT57 | Individual Protein | Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens | IC50 | = | 1522.67 | nM | PubChem BioAssay data set |
NPT60 | Individual Protein | Lysosomal alpha-glucosidase | Homo sapiens | Potency | = | 1572.8 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 100 | nM | PubChem BioAssay data set |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 177.8 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 446.7 | nM | PubChem BioAssay data set |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 1510.1 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 31.6 | nM | PubChem BioAssay data set | |
NPT1039 | Individual Protein | Envelope glycoprotein gp160 | Human immunodeficiency virus 1 | IC50 | = | 11200 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 19952.6 | nM | PubChem BioAssay data set | ||
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 707.9 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 2936.2 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 3294.4 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 26854.5 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 89.1 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 100 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 8.9 | nM | PubChem BioAssay data set | |
NPT1040 | Individual Protein | Human immunodeficiency virus type 1 Tat protein | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | IC50 | 556 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | CC50 | 40000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 195 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC7839 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC142291 |
0.9884 | High Similarity | NPC119094 |
0.9884 | High Similarity | NPC173872 |
0.9535 | High Similarity | NPC80956 |
0.9419 | High Similarity | NPC297574 |
0.9379 | High Similarity | NPC201814 |
0.9314 | High Similarity | NPC129533 |
0.9314 | High Similarity | NPC123259 |
0.9306 | High Similarity | NPC472723 |
0.927 | High Similarity | NPC472721 |
0.927 | High Similarity | NPC472720 |
0.927 | High Similarity | NPC31208 |
0.927 | High Similarity | NPC160543 |
0.927 | High Similarity | NPC93065 |
0.927 | High Similarity | NPC469652 |
0.927 | High Similarity | NPC472724 |
0.9227 | High Similarity | NPC3474 |
0.9213 | High Similarity | NPC477081 |
0.9213 | High Similarity | NPC269046 |
0.9213 | High Similarity | NPC477083 |
0.9213 | High Similarity | NPC240200 |
0.9213 | High Similarity | NPC158214 |
0.9213 | High Similarity | NPC223534 |
0.9213 | High Similarity | NPC290289 |
0.9209 | High Similarity | NPC111490 |
0.9209 | High Similarity | NPC261623 |
0.9195 | High Similarity | NPC473713 |
0.9162 | High Similarity | NPC187632 |
0.9157 | High Similarity | NPC65489 |
0.9157 | High Similarity | NPC237202 |
0.9157 | High Similarity | NPC469649 |
0.9157 | High Similarity | NPC260521 |
0.9153 | High Similarity | NPC231254 |
0.9148 | High Similarity | NPC8940 |
0.9128 | High Similarity | NPC149300 |
0.9116 | High Similarity | NPC477082 |
0.9116 | High Similarity | NPC476358 |
0.9111 | High Similarity | NPC97924 |
0.9111 | High Similarity | NPC264302 |
0.9111 | High Similarity | NPC40078 |
0.9111 | High Similarity | NPC471091 |
0.9101 | High Similarity | NPC469650 |
0.908 | High Similarity | NPC166674 |
0.908 | High Similarity | NPC46640 |
0.908 | High Similarity | NPC34436 |
0.908 | High Similarity | NPC263119 |
0.908 | High Similarity | NPC219600 |
0.908 | High Similarity | NPC473550 |
0.9075 | High Similarity | NPC181778 |
0.9075 | High Similarity | NPC470272 |
0.907 | High Similarity | NPC311389 |
0.907 | High Similarity | NPC470271 |
0.907 | High Similarity | NPC473818 |
0.904 | High Similarity | NPC170203 |
0.904 | High Similarity | NPC208797 |
0.904 | High Similarity | NPC53680 |
0.9023 | High Similarity | NPC100251 |
0.9023 | High Similarity | NPC65333 |
0.9017 | High Similarity | NPC658 |
0.9017 | High Similarity | NPC197708 |
0.9016 | High Similarity | NPC189312 |
0.9012 | High Similarity | NPC175793 |
0.8994 | High Similarity | NPC104910 |
0.8994 | High Similarity | NPC474093 |
0.8989 | High Similarity | NPC470718 |
0.8989 | High Similarity | NPC297503 |
0.8989 | High Similarity | NPC97119 |
0.8989 | High Similarity | NPC135831 |
0.8983 | High Similarity | NPC198902 |
0.8977 | High Similarity | NPC67629 |
0.8977 | High Similarity | NPC79736 |
0.8973 | High Similarity | NPC470450 |
0.8971 | High Similarity | NPC98583 |
0.896 | High Similarity | NPC261411 |
0.896 | High Similarity | NPC190204 |
0.896 | High Similarity | NPC43918 |
0.8944 | High Similarity | NPC475360 |
0.8944 | High Similarity | NPC72554 |
0.8944 | High Similarity | NPC30011 |
0.8944 | High Similarity | NPC97817 |
0.8944 | High Similarity | NPC475179 |
0.8939 | High Similarity | NPC25946 |
0.8939 | High Similarity | NPC470720 |
0.8939 | High Similarity | NPC470713 |
0.8939 | High Similarity | NPC21359 |
0.8939 | High Similarity | NPC460984 |
0.8939 | High Similarity | NPC470717 |
0.8933 | High Similarity | NPC125352 |
0.8927 | High Similarity | NPC267549 |
0.892 | High Similarity | NPC473630 |
0.8914 | High Similarity | NPC5786 |
0.8914 | High Similarity | NPC102851 |
0.8908 | High Similarity | NPC198125 |
0.8908 | High Similarity | NPC95421 |
0.8895 | High Similarity | NPC121290 |
0.8889 | High Similarity | NPC473554 |
0.8889 | High Similarity | NPC295625 |
0.8889 | High Similarity | NPC470719 |
0.8889 | High Similarity | NPC112380 |
0.8883 | High Similarity | NPC162394 |
0.8883 | High Similarity | NPC241781 |
0.8883 | High Similarity | NPC156785 |
0.8883 | High Similarity | NPC132111 |
0.8876 | High Similarity | NPC471030 |
0.8864 | High Similarity | NPC163165 |
0.8857 | High Similarity | NPC47521 |
0.8851 | High Similarity | NPC31034 |
0.884 | High Similarity | NPC105591 |
0.884 | High Similarity | NPC269625 |
0.8837 | High Similarity | NPC291957 |
0.8837 | High Similarity | NPC14030 |
0.8833 | High Similarity | NPC223860 |
0.8833 | High Similarity | NPC275977 |
0.8833 | High Similarity | NPC249560 |
0.8833 | High Similarity | NPC318119 |
0.8827 | High Similarity | NPC117668 |
0.8827 | High Similarity | NPC469371 |
0.882 | High Similarity | NPC113836 |
0.882 | High Similarity | NPC476620 |
0.882 | High Similarity | NPC37668 |
0.882 | High Similarity | NPC476622 |
0.882 | High Similarity | NPC293626 |
0.882 | High Similarity | NPC476618 |
0.882 | High Similarity | NPC476623 |
0.882 | High Similarity | NPC476619 |
0.882 | High Similarity | NPC253521 |
0.882 | High Similarity | NPC258044 |
0.882 | High Similarity | NPC267680 |
0.882 | High Similarity | NPC217387 |
0.882 | High Similarity | NPC196127 |
0.882 | High Similarity | NPC476621 |
0.8817 | High Similarity | NPC174140 |
0.8807 | High Similarity | NPC47140 |
0.8807 | High Similarity | NPC38438 |
0.8807 | High Similarity | NPC67134 |
0.8786 | High Similarity | NPC470898 |
0.8785 | High Similarity | NPC221140 |
0.8785 | High Similarity | NPC473686 |
0.8785 | High Similarity | NPC33083 |
0.8785 | High Similarity | NPC475352 |
0.8785 | High Similarity | NPC475220 |
0.8785 | High Similarity | NPC229817 |
0.8778 | High Similarity | NPC321916 |
0.8771 | High Similarity | NPC472726 |
0.8771 | High Similarity | NPC472725 |
0.8764 | High Similarity | NPC144097 |
0.8764 | High Similarity | NPC61904 |
0.8757 | High Similarity | NPC175230 |
0.8757 | High Similarity | NPC88560 |
0.8757 | High Similarity | NPC316539 |
0.8757 | High Similarity | NPC172033 |
0.875 | High Similarity | NPC204937 |
0.875 | High Similarity | NPC149011 |
0.8743 | High Similarity | NPC249977 |
0.8736 | High Similarity | NPC179947 |
0.8736 | High Similarity | NPC64755 |
0.8729 | High Similarity | NPC470451 |
0.8729 | High Similarity | NPC470416 |
0.8729 | High Similarity | NPC470455 |
0.8728 | High Similarity | NPC476371 |
0.8728 | High Similarity | NPC285108 |
0.8728 | High Similarity | NPC33298 |
0.8728 | High Similarity | NPC476372 |
0.8721 | High Similarity | NPC289346 |
0.8721 | High Similarity | NPC24627 |
0.8721 | High Similarity | NPC24164 |
0.8715 | High Similarity | NPC477895 |
0.8715 | High Similarity | NPC217520 |
0.8715 | High Similarity | NPC35167 |
0.8715 | High Similarity | NPC472387 |
0.8715 | High Similarity | NPC139571 |
0.8715 | High Similarity | NPC173837 |
0.8713 | High Similarity | NPC238419 |
0.8713 | High Similarity | NPC172419 |
0.8708 | High Similarity | NPC34267 |
0.8708 | High Similarity | NPC81042 |
0.8708 | High Similarity | NPC253685 |
0.8708 | High Similarity | NPC214621 |
0.8708 | High Similarity | NPC171706 |
0.8708 | High Similarity | NPC223426 |
0.8689 | High Similarity | NPC205721 |
0.8689 | High Similarity | NPC473618 |
0.8681 | High Similarity | NPC87583 |
0.8678 | High Similarity | NPC227297 |
0.8674 | High Similarity | NPC473717 |
0.8674 | High Similarity | NPC473631 |
0.8674 | High Similarity | NPC199172 |
0.8674 | High Similarity | NPC470445 |
0.8674 | High Similarity | NPC470446 |
0.8674 | High Similarity | NPC470447 |
0.8674 | High Similarity | NPC470449 |
0.8674 | High Similarity | NPC36138 |
0.8674 | High Similarity | NPC35924 |
0.8674 | High Similarity | NPC293227 |
0.8674 | High Similarity | NPC475662 |
0.8667 | High Similarity | NPC212290 |
0.8663 | High Similarity | NPC104222 |
0.8663 | High Similarity | NPC87317 |
0.8663 | High Similarity | NPC114791 |
0.8663 | High Similarity | NPC210501 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC7839 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9023 | High Similarity | NPD7993 | Clinical (unspecified phase) |
0.8655 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8603 | High Similarity | NPD7808 | Phase 3 |
0.8547 | High Similarity | NPD7251 | Discontinued |
0.8539 | High Similarity | NPD7472 | Approved |
0.8539 | High Similarity | NPD7074 | Phase 3 |
0.85 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8492 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8483 | Intermediate Similarity | NPD7054 | Approved |
0.8453 | Intermediate Similarity | NPD8313 | Approved |
0.8453 | Intermediate Similarity | NPD8312 | Approved |
0.843 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8427 | Intermediate Similarity | NPD7228 | Approved |
0.8418 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8418 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8418 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8324 | Intermediate Similarity | NPD3818 | Discontinued |
0.8278 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8235 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.8177 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8128 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.8114 | Intermediate Similarity | NPD8455 | Phase 2 |
0.8079 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8071 | Intermediate Similarity | NPD8151 | Discontinued |
0.8065 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.8056 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.8045 | Intermediate Similarity | NPD7199 | Phase 2 |
0.8043 | Intermediate Similarity | NPD7240 | Approved |
0.8034 | Intermediate Similarity | NPD6234 | Discontinued |
0.7967 | Intermediate Similarity | NPD7473 | Discontinued |
0.7955 | Intermediate Similarity | NPD37 | Approved |
0.7946 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7921 | Intermediate Similarity | NPD4966 | Approved |
0.7921 | Intermediate Similarity | NPD4965 | Approved |
0.7921 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7901 | Intermediate Similarity | NPD6232 | Discontinued |
0.7853 | Intermediate Similarity | NPD1934 | Approved |
0.7845 | Intermediate Similarity | NPD6959 | Discontinued |
0.7829 | Intermediate Similarity | NPD1653 | Approved |
0.7826 | Intermediate Similarity | NPD3751 | Discontinued |
0.7778 | Intermediate Similarity | NPD7075 | Discontinued |
0.7765 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7727 | Intermediate Similarity | NPD7435 | Discontinued |
0.7722 | Intermediate Similarity | NPD3882 | Suspended |
0.7717 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7709 | Intermediate Similarity | NPD7819 | Suspended |
0.7709 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7705 | Intermediate Similarity | NPD3787 | Discontinued |
0.767 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7667 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.766 | Intermediate Similarity | NPD6559 | Discontinued |
0.7638 | Intermediate Similarity | NPD7697 | Approved |
0.7638 | Intermediate Similarity | NPD7696 | Phase 3 |
0.7638 | Intermediate Similarity | NPD7680 | Approved |
0.7638 | Intermediate Similarity | NPD7698 | Approved |
0.7635 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7635 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7614 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7611 | Intermediate Similarity | NPD2801 | Approved |
0.7611 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.76 | Intermediate Similarity | NPD7870 | Phase 2 |
0.76 | Intermediate Similarity | NPD8320 | Phase 1 |
0.76 | Intermediate Similarity | NPD8319 | Approved |
0.76 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7596 | Intermediate Similarity | NPD5494 | Approved |
0.7586 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7586 | Intermediate Similarity | NPD7874 | Approved |
0.7582 | Intermediate Similarity | NPD3749 | Approved |
0.7576 | Intermediate Similarity | NPD6779 | Approved |
0.7576 | Intermediate Similarity | NPD6781 | Approved |
0.7576 | Intermediate Similarity | NPD6778 | Approved |
0.7576 | Intermediate Similarity | NPD6782 | Approved |
0.7576 | Intermediate Similarity | NPD6777 | Approved |
0.7576 | Intermediate Similarity | NPD6780 | Approved |
0.7576 | Intermediate Similarity | NPD6776 | Approved |
0.7574 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7569 | Intermediate Similarity | NPD5402 | Approved |
0.7542 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7527 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7514 | Intermediate Similarity | NPD1512 | Approved |
0.75 | Intermediate Similarity | NPD7411 | Suspended |
0.7486 | Intermediate Similarity | NPD6190 | Approved |
0.7475 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7475 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7463 | Intermediate Similarity | NPD7801 | Approved |
0.7461 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7459 | Intermediate Similarity | NPD6801 | Discontinued |
0.7457 | Intermediate Similarity | NPD7266 | Discontinued |
0.7429 | Intermediate Similarity | NPD3750 | Approved |
0.7401 | Intermediate Similarity | NPD1511 | Approved |
0.7401 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7374 | Intermediate Similarity | NPD5403 | Approved |
0.7371 | Intermediate Similarity | NPD8150 | Discontinued |
0.7366 | Intermediate Similarity | NPD8127 | Discontinued |
0.7323 | Intermediate Similarity | NPD6534 | Approved |
0.7323 | Intermediate Similarity | NPD6535 | Approved |
0.7311 | Intermediate Similarity | NPD8155 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD6799 | Approved |
0.7293 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7293 | Intermediate Similarity | NPD7458 | Discontinued |
0.7273 | Intermediate Similarity | NPD6674 | Discontinued |
0.7267 | Intermediate Similarity | NPD230 | Phase 1 |
0.7263 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7263 | Intermediate Similarity | NPD5401 | Approved |
0.7253 | Intermediate Similarity | NPD6599 | Discontinued |
0.7232 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7216 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7216 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7209 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7209 | Intermediate Similarity | NPD1613 | Approved |
0.7198 | Intermediate Similarity | NPD3226 | Approved |
0.7196 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7179 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7175 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7159 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7159 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7157 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7143 | Intermediate Similarity | NPD3748 | Approved |
0.7083 | Intermediate Similarity | NPD5619 | Clinical (unspecified phase) |
0.7079 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7074 | Intermediate Similarity | NPD919 | Approved |
0.7072 | Intermediate Similarity | NPD2534 | Approved |
0.7072 | Intermediate Similarity | NPD2533 | Approved |
0.7072 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7072 | Intermediate Similarity | NPD2532 | Approved |
0.7067 | Intermediate Similarity | NPD7585 | Approved |
0.7053 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7039 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7033 | Intermediate Similarity | NPD6273 | Approved |
0.7019 | Intermediate Similarity | NPD7583 | Approved |
0.7018 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7005 | Intermediate Similarity | NPD5353 | Approved |
0.6994 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.699 | Remote Similarity | NPD7549 | Discontinued |
0.6989 | Remote Similarity | NPD7097 | Phase 1 |
0.6978 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.6976 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6949 | Remote Similarity | NPD1510 | Phase 2 |
0.6944 | Remote Similarity | NPD8166 | Discontinued |
0.6944 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6936 | Remote Similarity | NPD3027 | Phase 3 |
0.6931 | Remote Similarity | NPD6214 | Clinical (unspecified phase) |
0.6931 | Remote Similarity | NPD6213 | Phase 3 |
0.6931 | Remote Similarity | NPD6212 | Phase 3 |
0.6923 | Remote Similarity | NPD7390 | Discontinued |
0.6911 | Remote Similarity | NPD1247 | Approved |
0.691 | Remote Similarity | NPD2796 | Approved |
0.691 | Remote Similarity | NPD6100 | Approved |
0.691 | Remote Similarity | NPD6099 | Approved |
0.6897 | Remote Similarity | NPD6798 | Discontinued |
0.6879 | Remote Similarity | NPD4908 | Phase 1 |
0.6875 | Remote Similarity | NPD447 | Suspended |
0.6875 | Remote Similarity | NPD1933 | Approved |
0.6875 | Remote Similarity | NPD6355 | Discontinued |
0.6857 | Remote Similarity | NPD7584 | Approved |
0.6854 | Remote Similarity | NPD651 | Clinical (unspecified phase) |
0.6851 | Remote Similarity | NPD7003 | Approved |
0.6839 | Remote Similarity | NPD5242 | Approved |
0.6821 | Remote Similarity | NPD7177 | Discontinued |
0.6818 | Remote Similarity | NPD943 | Approved |
0.6818 | Remote Similarity | NPD4060 | Phase 1 |
0.6816 | Remote Similarity | NPD6841 | Approved |
0.6816 | Remote Similarity | NPD6843 | Phase 3 |
0.6816 | Remote Similarity | NPD1551 | Phase 2 |
0.6816 | Remote Similarity | NPD6842 | Approved |
0.681 | Remote Similarity | NPD7211 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD3764 | Approved |
0.68 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6791 | Remote Similarity | NPD7930 | Approved |
0.6782 | Remote Similarity | NPD4287 | Approved |
0.678 | Remote Similarity | NPD7667 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD7039 | Approved |
0.6768 | Remote Similarity | NPD7038 | Approved |
0.6763 | Remote Similarity | NPD8285 | Discontinued |
0.6761 | Remote Similarity | NPD6233 | Phase 2 |
0.6757 | Remote Similarity | NPD8058 | Clinical (unspecified phase) |
0.6757 | Remote Similarity | NPD8059 | Phase 3 |
0.6755 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD8053 | Approved |
0.675 | Remote Similarity | NPD8054 | Approved |
0.6737 | Remote Similarity | NPD4288 | Approved |
0.6725 | Remote Similarity | NPD9269 | Phase 2 |
0.6723 | Remote Similarity | NPD1240 | Approved |
0.6722 | Remote Similarity | NPD5404 | Approved |
0.6722 | Remote Similarity | NPD5405 | Approved |
0.6722 | Remote Similarity | NPD2935 | Discontinued |
0.6722 | Remote Similarity | NPD5406 | Approved |
0.6722 | Remote Similarity | NPD5408 | Approved |
0.6717 | Remote Similarity | NPD5953 | Discontinued |
0.6705 | Remote Similarity | NPD3268 | Approved |
0.6701 | Remote Similarity | NPD5710 | Approved |
0.6701 | Remote Similarity | NPD5711 | Approved |
0.6685 | Remote Similarity | NPD5124 | Phase 1 |
0.6685 | Remote Similarity | NPD2346 | Discontinued |
0.6685 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD6385 | Approved |
0.6667 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD5005 | Approved |
PubChem CID   | 16745534 |
ChEMBL   | CHEMBL1391063 |
ZINC   |
Molecular Weight:   | 956.11 |
ALogP:   | -6.8232 |
MLogP:   | 3 |
XLogP:   | -0.838 |
# Rotatable Bonds:   | 25 |
Polar Surface Area:   | 447.09 |
# H-Bond Aceptor:   | 15 |
# H-Bond Donor:   | 13 |
# Rings:   | 7 |
# Heavy Atoms:   | 68 |